Effect of amitriptyline on lipid deposition and biochemical metabolism in a cell model of nonalcoholic fatty liver disease

Qin LIU; Qiang ZHANG; Fangxiong WU; Rong YAN; Rong LI; Jia WANG; Chunyan NIU

doi:10.3969/j.issn.1001-5256.2021.01.020

Volume 37 Issue 1

Jan. 2021

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2021 > 37(1): 99-104

PDF( 2482 KB)

Effect of amitriptyline on lipid deposition and biochemical metabolism in a cell model of nonalcoholic fatty liver disease

DOI: 10.3969/j.issn.1001-5256.2021.01.020

1.
School of Medicine, Xiamen University, Xiamen, Fujian 361102, China
2.
Department of Gastroenterology, The First Affiliated Hospital of Xi′an Medical University, Xi′an 710077, China
3.
Nanjing Lishui People's Hospital; Department of Gastroenterology, Lishui Branch of Zhongda Hospital Affiliated to Southeast University, Nanjing 211200, China

Received Date: 2020-06-11
Accepted Date: 2020-08-28
Published Date: 2021-01-20

Abstract

Abstract

Objective To investigate the effect of amitriptyline on lipid deposition and biochemical metabolism in a cell model of nonalcoholic fatty liver disease (NAFLD) by regulating the acid sphingomyelinase (ASM)/ceramide (CE) pathway. Methods HepG2 and L02 cells were cultured in vitro to establish a cell model of NAFLD. MTT colorimetry was used to measure cell proliferation rate, and oil red O staining was used to observe the change of lipid droplets in cells. In the experiment, the cells were divided into normal control group, model group, Ami group, TNFα group, and Ami+TNFα group. An automatic biochemical analyzer was used to measure the levels of triglyceride (TG) and total cholesterol (TC) in cells and the levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in supernatant; ELISA was used to measure the levels of CE and ASM in cells; Western blot was used to measure the protein expression ASM in cells, and RT-PCR was used to measure the mRNA expression of ASM in cells. A one-way analysis of variance was used for comparison of continuous data between multiple groups, and the Turkey test was used for further comparison between two groups. Results Compared with the normal control group, the NAFLD model group had significant increases in the protein and mRNA expression of ASM and the levels of CE, TG, TC, ALT, and AST (all P < 0.05). Compared with the model group, the Ami group had significant reductions in the protein and mRNA expression of ASM and the levels of CE, TG, TC, ALT, and AST (all P < 0.05), and the TNFα group had significant increases in the protein and mRNA expression of ASM and the levels of CE, TG, ALT, and AST (all P < 0.05). Compared with the TNFα group, the Ami+TNFα group had significant reductions in the protein and mRNA expression of ASM and the levels of CE, TG, TC, ALT, and AST (all P < 0.05). Conclusion The ASM/CE pathway promotes lipid accumulation and may lead to hepatocyte steatosis, and amitriptyline can alleviate lipid deposition in NAFLD hepatocytes by inhibiting the ASM/CE pathway.
- Non-alcoholic Fatty Liver Disease,
- Amitriptyline,
- PhospHolipases,
- Ceramides,
- Lipidoses

FullText(HTML)

References(17)

References

[1]	MUNDI MS, VELAPATI S, PATEL J, et al. Evolution of NAFLD and its management[J]. Nutr Clin Pract, 2020, 35(1): 72-84. DOI: 10.1002/ncp.10449
[2]	JIANG YZ, NIE HM, WANG R. Research advances in the pathogenesis of nonalcoholic fatty liver disease[J]. J Clin Hepatol, 2019, 35(11): 2588-2591. (in Chinese) DOI: 10.3969/j.issn.1001-5256.2019.11.044 姜煜资, 聂红明, 汪蓉. 非酒精性脂肪性肝病的发病机制[J]. 临床肝胆病杂志, 2019, 35(11): 2588-2591. DOI: 10.3969/j.issn.1001-5256.2019.11.044
[3]	BECKMANN N, SHARMA D, GULBINS E, et al. Inhibition of acid sphingomyelinase by tricyclic antidepressants and analogons[J]. Front Physiol, 2014, 5: 331. http://www.ncbi.nlm.nih.gov/pubmed/25228885
[4]	YANG L, JIN GH, ZHOU JY. The role of ceramide in the pathogenesis of alcoholic liver disease[J]. Alcohol Alcohol, 2016, 51(3): 251-257. DOI: 10.1093/alcalc/agv119
[5]	RÉGNIER M, POLIZZI A, GUILLOU H, et al. Sphingolipid metabolism in non-alcoholic fatty liver diseases[J]. Biochimie, 2019, 159: 9-22. DOI: 10.1016/j.biochi.2018.07.021
[6]	UNGER RH. Lipotoxic diseases[J]. Annu Rev Med, 2002, 53(4): 319-336.
[7]	MALDONADO-HERNÁNDEZ J, SALDAÑA-DÁVILA GE, PIÑA-AGUERO MI, et al. Association between plasmatic ceramides profile and AST/ALT Ratio: C14:0 ceramide as predictor of hepatic steatosis in adolescents independently of obesity[J]. Can J Gastroenterol Hepatol, 2017, 2017: 3689375.
[8]	APOSTOLOPOULOU M, GORDILLO R, KOLIAKI C, et al. Specific hepatic sphingolipids relate to insulin resistance, oxidative stress, and inflammation in nonalcoholic steatohepatitis[J]. Diabetes Care, 2018, 41(6): 1235-1243. DOI: 10.2337/dc17-1318
[9]	LUUKKONEN PK, ZHOU Y, SÄDEVIRTA S, et al. Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease[J]. J Hepatol, 2016, 64(5): 1167-1175. DOI: 10.1016/j.jhep.2016.01.002
[10]	HU Y, LIU ZX, FU N, et al. Role of ceramide in hepatic lipid accumulation in rats with non-alcoholic fatty liver disease[J]. World Chin J Dig, 2015, 23(32): 5196-5200. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-XXHB201532019.htm 胡杨, 刘朝霞, 傅念, 等. 神经酰胺在非酒精性脂肪肝大鼠肝细胞脂质沉积中的作用[J]. 世界华人消化杂志, 2015, 23(32): 5196-5200. https://www.cnki.com.cn/Article/CJFDTOTAL-XXHB201532019.htm
[11]	FERNANDEZ A, MATIAS N, FUCHO R, et al. ASMase is required for chronic alcohol induced hepatic endoplasmic reticulum stress and mitochondrial cholesterol loading[J]. J Hepatol, 2013, 59(4): 805-813. DOI: 10.1016/j.jhep.2013.05.023
[12]	FUCHO R, MARTÍNEZ L, BAULIES A, et al. ASMase regulates autophagy and lysosomal membrane permeabilization and its inhibition prevents early stage non-alcoholic steatohepatitis[J]. J Hepatol, 2014, 61(5): 1126-1134. DOI: 10.1016/j.jhep.2014.06.009
[13]	LIANGPUNSAKUL S, RAHMINI Y, ROSS RA, et al. Imipramine blocks ethanol-induced ASMase activation, ceramide generation, and PP2A activation, and ameliorates hepatic steatosis in ethanol-fed mice[J]. Am J Physiol Gastrointest Liver Physiol, 2012, 302(5): g515-g523. DOI: 10.1152/ajpgi.00455.2011
[14]	GARCIA-RUIZ C, MATO JM, VANCE D, et al. Acid sphingomyelinase-ceramide system in steatohepatitis: A novel target regulating multiple pathways[J]. J Hepatol, 2015, 62(1): 219-233. DOI: 10.1016/j.jhep.2014.09.023
[15]	MVHLE C, WEINLAND C, GULBINS E, et al. Peripheral acid sphingomyelinase activity is associated with biomarkers and phenotypes of alcohol use and dependence in patients and healthy controls[J]. Int J Mol Sci, 2018, 19(12): 4028. DOI: 10.3390/ijms19124028
[16]	GUAN Y, LI X, UMETANI M, et al. Tricyclic antidepressant amitriptyline inhibits autophagic flux and prevents tube formation in vascular endothelial cells[J]. Basic Clin Pharmacol Toxicol, 2019, 124(4): 370-384. DOI: 10.1111/bcpt.13146
[17]	LU Z, LI Y, SYN WK, et al. Amitriptyline inhibits nonalcoholic steatohepatitis and atherosclerosis induced by high-fat diet and LPS through modulation of sphingolipid metabolism[J]. Am J Physiol Endocrinol Metab, 2020, 318(2): e131-e144. DOI: 10.1152/ajpendo.00181.2019

Relative Articles

[1]	Du YiChao, Zhang Hao, Zhong FuRui, Cheng HuanLi, Lai Li, Qian BaoLin, Tan Peng, Xia XianMing, Fu WenGuang. Protective effect of pinocembrin in a mouse model of liver injury induced by acetaminophen[J]. Journal of Clinical Hepatology, 2020, 36(3): 608-611. doi: 10.3969/j.issn.1001-5256.2020.03.027
[3]	Li Yang, Shu DeJun, Peng CiJun, Feng ZanJie, Mei Yong, Xiong Kun. Effect of erythropoietin on the mRNA expression of apoptosis genes bcl-2 and bax in rats with fatty liver disease after hepatic ischemia-reperfusion injury[J]. Journal of Clinical Hepatology, 2019, 35(1): 157-160. doi: 10.3969/j.issn.1001-5256.2019.01.030
[4]	Lu Xin, Liu Ying, Jia Lei, Kong LingYu, Liu DianQing. Role of D-bifunctional protein in promoting the growth of hepatocellular carcinoma in rats and nude mice[J]. Journal of Clinical Hepatology, 2019, 35(7): 1532-1535. doi: 10.3969/j.issn.1001-5256.2019.07.022
[5]	Wang Hao, He Cheng, Chen Hao, Ou YangZhongMin, Liu ZhiQiang. Value of Gd-EOB-DTPA-enhanced MRI in the assessment of liver function in dogs with acute liver failure[J]. Journal of Clinical Hepatology, 2019, 35(7): 1576-1581. doi: 10.3969/j.issn.1001-5256.2019.07.030
[6]	Zhang YongChao, Bi YanZhen, Fang Xiao, Wang QuanYi, Wang QuanQuan, Tang HuiXin, Kong LingBin, Chen Yu, Duan ZhongPing, Shu ZhenFeng, Hong Feng. Protective effect of probiotics in rats with acute-on-chronic liver failure and related mechanism[J]. Journal of Clinical Hepatology, 2019, 35(7): 1570-1575. doi: 10.3969/j.issn.1001-5256.2019.07.029
[7]	Wu LinLan, Xu Bing, Wei JianWei, Zhao ZhiPing, Huang SuQin, Yang XiaoMei. Therapeutical effect of local transplantation of bone marrow mesenchymal stem cells mixed with fibrin gel on rats with liver injury[J]. Journal of Clinical Hepatology, 2018, 34(8): 1740-1744. doi: 10.3969/j.issn.1001-5256.2018.08.029
[8]	Pan Qi, Luo ChunHai, Ma WanLing, Qu YuanFei, Wang JianRu, Chen Lin. Specific magnetic resonance imaging of vascular endothelial growth factor-C targeted molecular probe and its clinical significance in a rat model of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2018, 34(7): 1492-1496. doi: 10.3969/j.issn.1001-5256.2018.07.025
[9]	Liang Kai, Kong WeiZong, Chen Juan, Wang YingChun. Effect of trefoil factor 3 on intestinal mucous barrier in rats with nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2017, 33(8): 1552-1557. doi: 10.3969/j.issn.1001-5256.2017.08.029
[10]	Shi HongBo, Shi HongLin, Zhang XiangYing, Chen DeXi, Duan ZhongPing, Ren Feng. Protective effect of autophagy in mice with acute liver injury induced by D- galactosamine / lipopolysaccharide and related mechanisms[J]. Journal of Clinical Hepatology, 2017, 33(2): 329-333. doi: 10.3969/j.issn.1001-5256.2017.02.027
[11]	Li XiaoTian, Yin Yan, Guo YongZe, Zhou LiYun, You ZiXuan. Mechanism of action of 1,25(OH)_2D_3 in influencing the expression of interleukin-17 and macrophage inflammatory protein-3α and inhibiting the formation of liver fibrosis in rats[J]. Journal of Clinical Hepatology, 2016, 32(12): 2331-2336. doi: 10.3969/j.issn.1001-5256.2016.12.020
[12]	Li Dong, Lu ZhongHua, Gan JianHe. Establishment of a rat model of early-stage liver failure and Th17/Treg imbalance[J]. Journal of Clinical Hepatology, 2016, 32(5): 928-932. doi: 10.3969/j.issn.1001-5256.2016.05.025
[13]	Li XiaoPeng, Li Ming, Lei Wan, Zhang LunLi. Protective effect of magnesium isoglycyrrhizinate in rats with acute liver failure induced by D- galactosamine[J]. Journal of Clinical Hepatology, 2016, 32(3): 545-548. doi: 10.3969/j.issn.1001-5256.2016.03.032
[14]	Lai JieYing, Song SiYu, Hao LiPing, Zhang XiaoLi. Localization and therapeutic effect of bone marrow hematopoietic cell transplantation in rat model of liver fibrosis[J]. Journal of Clinical Hepatology, 2015, 31(11): 1878-1882. doi: 10.3969/j.issn.1001-5256.2015.11.026
[15]	Xu ZhongNan, Wu XiMing, Wang Pei, Zhang XiQuan, Xia ChunGuang, Wang XunQiang, Wang Yang, Zhan XiaoLe, Qu Ying, Xu MingYi, Lu LunGen. 18α glycyrrhizic acid in the treatment of acute liver injury induced by D-galactosamine in rats[J]. Journal of Clinical Hepatology, 2012, 28(1): 63-65+70.
[16]	Lu XiaoJu, Chen YongPing, Yang Tao, Shen ChunYan. Effect of baicalin of the expression of NF-κB in acute liver failure in rats[J]. Journal of Clinical Hepatology, 2011, 27(10): 1087-1092.
[17]	Wang JiPing, Leng JiYan, Dong Dong, Yan WeiQun. The protective effect of rhKD/APP on liver injured by D-galactosamine in rats[J]. Journal of Clinical Hepatology, 2007, 23(1): 24-25.
[19]	Wang JunXue, Wang GuoJun, Cai Xiong. The effects of oxymatrine on apoptosis induced by TNF-α in human liver cell line L02[J]. Journal of Clinical Hepatology, 2001, 17(4): 210-211+217.

Supplements(0)

Cited By

Cited by

Periodical cited type(6)

1.	黄成，崔海坡，谭蔚锋，芦映希，姜赫宣. 肝门阻断夹持器齿型对夹持性能的影响. 生物医学工程学进展. 2022(03): 139-143 .
2.	吴均政. 腹腔镜Pringle法联合左肝静脉阻断对左半肝切除术患者术中出血量及凝血指标的影响. 中外医学研究. 2021(26): 45-48 .
3.	石川，常华，豆松萌，李恒. Pringle联合IVC法在巨大肝血管瘤切除术中的应用效果分析. 河南外科学杂志. 2021(06): 30-33 .
4.	汪长青，吴珍宝. 不同肝血流阻断对腹腔镜肝切除术患者的影响. 西南国防医药. 2019(02): 116-118 .
5.	刘雄友，高德山，郭忠涛. 不同肝血流阻断方式对肝切除术安全性及预后的影响. 肝胆外科杂志. 2018(01): 42-46 .
6.	殷杰，徐新宝，朱日祥. 腹腔镜肝切除术治疗肝血管瘤58例临床分析. 中华肝脏外科手术学电子杂志. 2018(06): 469-472 .

Other cited types(2)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(3) / Tables(9)

Get Citation

PDF

XML

Article Metrics

Article views (1115) PDF downloads(39)

Effect of amitriptyline on lipid deposition and biochemical metabolism in a cell model of nonalcoholic fatty liver disease

DOI: 10.3969/j.issn.1001-5256.2021.01.020